TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Open Access
- 21 June 2022
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 77 (4) , 991-1004
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferationJournal of Clinical Investigation, 2014
- Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitisHepatology, 2014
- Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor–induced TIMP-1 gene transcription in hepatic stellate cells in miceHepatology, 2012
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gutThe Journal of Physiology, 2012
- Current consensus on the management of primary sclerosing cholangitisClinics and Research in Hepatology and Gastroenterology, 2011
- Bicarbonate Secretion of Mouse Cholangiocytes Involves Na+-Hco3 − Cotransport in Addition to Na+-Independent Cl−/Hco3 − ExchangeHepatology, 2009
- From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infectionImmunobiology, 2008
- TLR4 enhances TGF-β signaling and hepatic fibrosisNature Medicine, 2007
- Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosisJournal of Hepatology, 2007
- Contribution of Toll‐like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration†Hepatology, 2005